Santa Fe Partners’s AbbVie ABBV Stock Holding History

Santa Fe Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,877	Closed	-$809K	–	441
2015 Q3	$809K	Sell	14,877 -12,424	-46%	-$809K	0.11%	292
2015 Q2	$1.83M	Buy	+27,301	New	+$1.78M	0.25%	166
2015 Q1	–	Sell	-38,518	Closed	-$2.52M	–	485
2014 Q4	$2.52M	Buy	38,518 +28,833	+298%	+$1.82M	0.32%	114
2014 Q3	$560K	Buy	+9,685	New	+$538K	0.09%	364

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Santa Fe Partners's ABBV Position: Q4 2015 in Review

Santa Fe Partners sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 14,877 shares — an estimated $809K sold.

Santa Fe Partners first reported a position in ABBV in Q3 2014 and held it in 4 quarters. The position peaked at $2.52M in Q4 2014. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Santa Fe Partners reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
Santa Fe Partners sold 14,877 AbbVie shares in Q4 2015, an estimated $809K.
Santa Fe Partners first reported a position in AbbVie in Q3 2014 and held it in 4 quarters.
Santa Fe Partners's AbbVie position peaked at $2.52M in Q4 2014.
1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.